Latest / US News Today | 2 Min News | The Daily News Now!
FDA Approves Wearable Sarclisa for Myeloma | US News
FDA just approved a game-changing wearable injector for Sanofi’s Sarclisa, letting patients with multiple myeloma get treatment under the skin instead of sitting through long IV drips. This new subcutaneous version, called Sarclisa Escena, offers a more flexible, less disruptive option for ongoing care — a major win for patients and healthcare teams alike. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public reporting.Report issues to feedback@thednn.ai. View…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.